Table 1.

Alterations to current and planned treatments.

Alterations to treatments	Global (N = 6,603)		Europe (N = 4,433)		Oceania (N = 374)		North America (N = 961)		Latin America and Caribbean (N = 649)
	No.	%	No.	%	No.	%	No.	%	No.	%
No impact	4,267	64.62	2,898	65.37	231	61.76	597	62.12	419	64.56
Difficulty with repeat prescriptions	1,337	20.25	853	19.24	105	28.07	205	21.33	127	19.57
Change hormone treatments	295	4.47	207	4.67	9	2.41	42	4.37	25	3.85
Change painkillers	459	6.95	331	7.47	29	7.75	50	5.20	34	5.24
Stop hormone treatments	222	3.36	150	3.38	7	1.87	24	2.50	32	4.93
Stop painkillers	434	6.57	295	6.65	26	6.95	55	5.72	44	6.78
Alterations to planned treatments	Global (N = 4,943)		Europe (N = 3,266)		Oceania (N = 264)		North America (N = 676)		Latin America and Caribbean (N = 587)
	No.	%	No.	%	No.	%	No.	%	No.	%
Gynaecologist appointments cancelled/postponed	2,473	50.03	1,696	51.93	88	33.33	294	43.49	321	54.68
GP appointments cancelled/postponed	726	14.69	455	13.93	27	10.23	121	17.90	96	16.35
Surgeries cancelled/postponed	1,333	26.97	840	25.72	112	42.42	222	32.84	128	21.81
Fertility treatments cancelled/postponed	591	11.96	400	12.25	25	9.47	75	11.09	76	12.95

Global and regional results for Europe, Oceania, North America, Latin America, and Caribbean to the questions “Has the pandemic altered the availability of your treatments for endometriosis?” and “Has the pandemic altered your planned treatments relating to endometriosis?” For clarity, the table includes answers that had more than 5% frequency. Regions are defined as per the WHO recommendations (https://www.ghsindex.org/). Data presented as frequencies (No.) and percentages (%). Percentages are calculated using the number of responders in each region for each question as the denominator.